Queen’s and a nationally recognized academic medical center to provide clinical expertise to enhance GE HealthCare’s forthcoming software solution- New software solution will use AI and predictive ...
Confirmation by several European agencies and the U.S. FDA of the relevance of the continuous abstinence validation criteria which showed statistical significance (p=0.02) in the Phase 2 CESTO II ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果